Cargando…
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma
BACKGROUND: Diffuse intrinsic pontine glioma (DIPG) and other diffuse midline gliomas (DMG) of the thalamus and spinal cord are rare but devastating high-grade glial tumors of childhood with no curative treatment. Despite aggressive treatment attempts the prognosis has remained poor. Chimeric antige...
Autores principales: | Wang, Stacie S, Davenport, Alexander J, Iliopoulos, Melinda, Hughes-Parry, Hannah E, Watson, Katherine A, Arcucci, Valeria, Mulazzani, Matthias, Eisenstat, David D, Hansford, Jordan R, Cross, Ryan S, Jenkins, Misty R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158089/ https://www.ncbi.nlm.nih.gov/pubmed/37152812 http://dx.doi.org/10.1093/noajnl/vdad024 |
Ejemplares similares
-
Receptor-driven invasion profiles in diffuse intrinsic pontine glioma
por: Karki, Anju, et al.
Publicado: (2021) -
Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma
por: Duchatel, Ryan J, et al.
Publicado: (2021) -
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma
por: Abbott, Rebecca C, et al.
Publicado: (2023) -
Leptomeningeal disease and tumor dissemination in a murine diffuse intrinsic pontine glioma model: implications for the study of the tumor-cerebrospinal fluid-ependymal microenvironment
por: Pan, Shelei, et al.
Publicado: (2022) -
A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma
por: Pandey, Kirti, et al.
Publicado: (2023)